EMCDDA Home
  • EN
Search

Tips: Click on a column heading to order the results.Use the filters to limit the number of results.

More help>>

Displaying results 1–2 of 2 where Substances addressed by the intervention is Ecstasy

<< previous next >>

Filter results:

Project description Intervention type Evaluation type Setting Target group Country Quality level
Title: The Ecstasy Group (The E group)
Summary: Describes a group of 8 young people who met for a period of 5 months because there was a professional need to better understand the new emerging youth culture around Ecstasy. The purpose of the group was to help develop and target interventions and services for young people and to help participants reduce or stop their ecstasy use. >>
process evaluation adults, children/young people Denmark 1
Title: Ecstacy Campaign: Don't Mess With Your Mind
Summary: The Alcohol and Drug Addiction Service of Oslo municipality conducted an information campaign directed at young people, focusing on ecstasy to prevent the spread of drug use. The message of the campaign was presented to the target group through short films at the cinema, advertisements in different teenage media and posters on buses, trams and the subway. >>
process evaluation adults, children/young people Norway 1

Displaying results 1–2 of 2 where Substances addressed by the intervention is Ecstasy

<< previous next >>

Survey

Dear visitor,

We're currently conducting a short survey of this resource (EDDRA: Exchange on Drug Demand Reduction Action). The survey will take no more than 2 minutes and we would be really grateful for your contribution.

No, thanks — maybe some other time

Yes, I'll take the survey!

Many thanks,

The EDDRA team

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 20 January 2012